Overview
Nucleotide ID | | c.1147_1154delinsTGTC |
| | |
Protein ID | | p.E383Cfs*46 |
| | |
Mutation | | Deletion+Insertion |
| | |
Type | | Type 2-like |
| | |
Class | | Class B |
| | |
Category | | #NA |
COSMIC | | COSV57125882 |
| | |
Pathologie | | Essential thrombocythaemia |
Structure
# PSIPRED HFORMAT (PSIPRED V4.0)
Conf: 935765027789999999999999999999999999999999999999999999439999
Pred: CHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHCCCCC
AA: AAEKQMKDKQDEEQRLKEEEEDKKRKEEEEACRRMMRTKMRMRRMRRTRRKMRRKMSPAR
10 20 30 40 50 60
Conf: 9832999998202129
Pred: CCCCHHHHHHHHHHCC
AA: PRTSCREACLQGWTEA
70
References
PMID | Citation |
---|
31554376 | Vu HA, Thao TT, Dong CV, et al. Clinical and Hematological Relevance of JAK2V617F, CALR, and MPL Mutations in Vietnamese Patients with Essential Thrombocythemia. Asian Pac J Cancer Prev. 2019.20(9):2775-2780. Published 2019 Sep 1. doi:10.31557/APJCP.2019.20.9.2775 |
25801912 | Palandri F, Latagliata R, Polverelli N, et al. Mutations and long-term outcome of 217 young patients with essential thrombocythemia or early primary myelofibrosis. Leukemia. 2015.29(6):1344-1349. doi:10.1038/leu.2015.87 |
25746303 | Li N, Yao QM, Gale RP, et al. Frequency and allele burden of CALR mutations in Chinese with essential thrombocythemia and primary myelofibrosis without JAK2(V617F) or MPL mutations. Leuk Res. 2015.39(5):510-514. doi:10.1016/j.leukres.2015.02.006 |